Avi Maimon
Impact in
-
- Phagocytosis and Immune Regulation
- Immune cells in cancer
Papers in
-
- Phagocytosis and Immune Regulation 4
- interferon and immune responses 1
- Immunotherapy and Immune Responses 1
-
- RNA modifications and cancer 3
- Single-cell and spatial transcriptomics 1
- Co-authors
- Tal Burstyn‐Cohen (4 shared papers)Ben Davidson (1 shared paper)Rotem Karni (1 shared paper)Zahava Siegfried (1 shared paper)Adrian R. Krainer (1 shared paper)Shivam Priya (2 shared papers)Amiram Ariel (1 shared paper)Sagie Schif‐Zuck (1 shared paper)
- Journals
- Advanced Science (2 papers)Frontiers in Immunology (2 papers)Cell Communication and Signaling (1 paper)iScience (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- IsraelGermanyUnited States
In The Last Decade
Avi Maimon
12 papers receiving 468 citations
Peers
Comparison fields: 5 of 61
- Immunology 187
- Cancer Research 45
- Physiology 72
- Molecular Biology 192
- Aging 4
Countries citing papers authored by Avi Maimon
This map shows the geographic impact of Avi Maimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Maimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Maimon more than expected).
Fields of papers citing papers by Avi Maimon
This network shows the impact of papers produced by Avi Maimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Maimon. The network helps show where Avi Maimon may publish in the future.
Co-authors
The 25 scholars most cited alongside Avi Maimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 114 | |
| 2 | 2019 | 85 | |
| 3 | 2024 | 73 | |
| 4 | 2021 | 59 | |
| 5 | 2018 | 52 | |
| 6 | 2024 | 35 | |
| 7 | 2017 | 34 | |
| 8 | 2022 | 7 | |
| 9 | 2025 | 7 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 2 | |
| 12 | 2025 | 1 |
About Avi Maimon
Avi Maimon is a scholar working on Immunology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Computational Theory and Mathematics, having authored 12 papers that have together received 473 indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (4 papers), RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers), Computational Drug Discovery Methods (2 papers), Single-cell and spatial transcriptomics (1 paper), Cancer-related molecular mechanisms research (1 paper), interferon and immune responses (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology (187 citations), Cancer Research (45 citations), Physiology (72 citations), Molecular Biology (192 citations) and Aging (4 citations). Avi Maimon has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Tal Burstyn‐Cohen, Ben Davidson, Rotem Karni, Zahava Siegfried, Adrian R. Krainer, Shivam Priya, Amiram Ariel, Sagie Schif‐Zuck, Ghada Abboud-Jarrous and Stuart L. Fischman. Their work appears in journals such as Advanced Science, Frontiers in Immunology, Cell Communication and Signaling, iScience and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.